Revvity Shares Rise on Launch of Child Type 1 Diabetes Screening Test

10:21 AM EDT, 09/24/2026 (MT Newswires) -- Revvity (RVTY) shares rose 3.7% in Thursday trading after the company launched its GSP T1D 3plex kit, a fully automated test that helps identify children at risk of developing type 1 diabetes before symptoms appear. The test uses dried blood spot samples and runs on Revvity's GSP instrument, enabling high-volume screening and potentially identifying at-risk individuals months or years before symptoms develop. The kit will launch in Europe and other markets that accept CE-IVD-approved diagnostics. Revvity said the test is not cleared by the US Food and Drug Administration. Price: 147.29, Change: +5.18, Percent Change: +3.65